Association of intraneural perineurioma with neurofibromatosis type 2



Neurofibromatosis type 2 (NF2) is a genetic disorder characterized by mutations of the NF2 tumor suppressor gene that predisposes patients to develop multiple tumors in the peripheral and central nervous system. The most common neoplasms associated with the disease are schwannomas and meningiomas. Both have been shown to contain abnormalities in chromosome 22 and the NF2 gene, suggesting a genetic component to their pathogenesis. Perineuriomas are rare benign tumors arising from the perineural cells. They are commonly classified as intraneural and soft tissue perineuriomas. Several studies have reported mutations in genes on chromosome 22 in both types of perineuriomas, and there are reports of soft tissue perineuriomas associated with NF2 gene mutations. Despite this, perineuriomas are not considered as part of the NF2 constellation of tumors.


The electronic medical records were searched for patients with a radiologic or pathologic diagnosis of intraneural perineurioma. Patients with clinical signs and genetic testing consistent with a diagnosis of NF2 were further evaluated.


Of 112 patients meeting inclusion criteria, there were two cases of intraneural perineurioma in patients with NF2 treated at our institution (1.8%). We include a third patient treated at another facility for whom we performed a virtual consultation.


The rarity of both NF2 and perineuriomas could explain the rarity of perineuriomas in the setting of NF2. Furthermore, there is divergent intraneural and soft tissue perineurioma somatic mutation pathogenesis, and there may be cytogenetic overlap between perineuriomas and multiple tumor syndromes. Our observed occurrence of intraneural perineurioma in the setting of NF2 in several patients provides further evidence of a potential link between the NF2 gene and the development of intraneural perineurioma.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4


  1. 1.

    Abyzov A, Urban AE, Snyder M, Gerstein M (2011) CNVnator: an approach to discover, genotype, and characterize typical and atypical CNVs from family and population genome sequencing. Genome Res 21:974–984.

    CAS  Article  Google Scholar 

  2. 2.

    Alkhaili J, Cambon-Binder A, Belkheyar Z (2018) Intraneural perineurioma: a retrospective study of 19 patients. Pan Afr Med J 30:275.

    Article  Google Scholar 

  3. 3.

    Asthagiri AR, Parry DM, Butman JA, Kim HJ, Tsilou ET, Zhuang Z, Lonser RR (2009) Neurofibromatosis type 2. Lancet 373:1974–1986.

    CAS  Article  Google Scholar 

  4. 4.

    Baser ME, De Rienzo A, Altomare D, Balsara BR, Hedrick NM, Gutmann DH, Pitts LH, Jackler RK, Testa JR (2002) Neurofibromatosis 2 and malignant mesothelioma. Neurology 59:290–291.

    CAS  Article  Google Scholar 

  5. 5.

    Boyanton BL Jr, Jones JK, Shenaq SM, Hicks MJ, Bhattacharjee MB (2007) Intraneural perineurioma: a systematic review with illustrative cases. Arch Pathol Lab Med 131:1382–1392.[1382:IPASRW]2.0.CO;2

    Article  Google Scholar 

  6. 6.

    Brock JE, Perez-Atayde AR, Kozakewich HP, Richkind KE, Fletcher JA, Vargas SO (2005) Cytogenetic aberrations in perineurioma: variation with subtype. Am J Surg Pathol 29:1164–1169.

    Article  Google Scholar 

  7. 7.

    Broski SM, Littrell LA, Howe BM, Folpe AL, Wenger DE (2020) Extraneural perineurioma: CT and MRI imaging characteristics. Skelet Radiol 49:109–114.

    Article  Google Scholar 

  8. 8.

    Carter JM, Wu Y, Blessing MM, Folpe AL, Thorland EC, Spinner RJ, Jentoft ME, Wang C, Baheti S, Niu Z, Mauermann ML, Klein CJ (2018) Recurrent genomic alterations in soft tissue perineuriomas. Am J Surg Pathol 42:1708–1714.

    Article  Google Scholar 

  9. 9.

    Chen L, Li Y, Lin JH (2005) Intraneural perineurioma in a child with Beckwith-Wiedemann syndrome. J Pediatr Surg 40:E12–E14.

    Article  Google Scholar 

  10. 10.

    Emory TS, Scheithauer BW, Hirose T, Wood M, Onofrio BM, Jenkins RB (1995) Intraneural perineurioma. A clonal neoplasm associated with abnormalities of chromosome 22. Am J Clin Pathol 103:696–704.

    CAS  Article  Google Scholar 

  11. 11.

    Evans DG, Huson SM, Donnai D, Neary W, Blair V, Newton V, Harris R (1992) A clinical study of type 2 neurofibromatosis. Q J Med 84:603–618

    CAS  Google Scholar 

  12. 12.

    Fetsch JF, Miettinen M (1997) Sclerosing perineurioma: a clinicopathologic study of 19 cases of a distinctive soft tissue lesion with a predilection for the fingers and palms of young adults. Am J Surg Pathol 21:1433–1442.

    CAS  Article  Google Scholar 

  13. 13.

    Giannini C, Scheithauer BW, Jenkins RB, Erlandson RA, Perry A, Borell TJ, Hoda RS, Woodruff JM (1997) Soft-tissue perineurioma. Evidence for an abnormality of chromosome 22, criteria for diagnosis, and review of the literature. Am J Surg Pathol 21:164–173.

    CAS  Article  Google Scholar 

  14. 14.

    Hornick JL, Fletcher CD (2005) Soft tissue perineurioma: clinicopathologic analysis of 81 cases including those with atypical histologic features. Am J Surg Pathol 29:845–858.

    Article  Google Scholar 

  15. 15.

    Huguet P, de la Torre J, Pallares J, Carrera M, Soler F, Espinet B, Malet D (2004) Intraosseous intraneural perineurioma: report of a case with morphological, immunohistochemical and FISH study. Med Oral 9:64–68

    Google Scholar 

  16. 16.

    Jacoby LB, MacCollin M, Louis DN, Mohney T, Rubio MP, Pulaski K, Trofatter JA, Kley N, Seizinger B, Ramesh V et al (1994) Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 3:413–419.

    CAS  Article  Google Scholar 

  17. 17.

    Klein CJ, Wu Y, Jentoft ME, Mer G, Spinner RJ, Dyck PJ, Dyck PJ, Mauermann ML (2017) Genomic analysis reveals frequent TRAF7 mutations in intraneural perineuriomas. Ann Neurol 81:316–321.

    CAS  Article  Google Scholar 

  18. 18.

    Lasota J, Fetsch JF, Wozniak A, Wasag B, Sciot R, Miettinen M (2001) The neurofibromatosis type 2 gene is mutated in perineurial cell tumors: a molecular genetic study of eight cases. Am J Pathol 158:1223–1229.

    CAS  Article  Google Scholar 

  19. 19.

    Lee HY, Manasseh RG, Edis RH, Page R, Keith-Rokosh J, Walsh P, Song S, Laycock A, Griffiths L, Fabian VA (2009) Intraneural perineurioma. J Clin Neurosci 16:1633–1636.

    Article  Google Scholar 

  20. 20.

    Macarenco RS, Ellinger F, Oliveira AM (2007) Perineurioma: a distinctive and underrecognized peripheral nerve sheath neoplasm. Arch Pathol Lab Med 131:625–636.[625:PADAUP]2.0.CO;2

    Article  Google Scholar 

  21. 21.

    Mauermann ML, Amrami KK, Kuntz NL, Spinner RJ, Dyck PJ, Bosch EP, Engelstad J, Felmlee JP, Dyck PJ (2009) Longitudinal study of intraneural perineurioma--a benign, focal hypertrophic neuropathy of youth. Brain 132:2265–2276.

    Article  Google Scholar 

  22. 22.

    Mauermann ML, Klein CJ, Dyck PJ, Engelstad J, Flynn Gilmer H, Jenkins RP, Dyck JB (2012) Fish analysis of chromosome 22 from peripheral nerve biopsies of intraneural perineurioma. Neurology 78(1):P05.146

  23. 23.

    Mott RT, Goodman BK, Burchette JL, Cummings TJ (2005) Loss of chromosome 13 in a case of soft tissue perineurioma. Clin Neuropathol 24:69–76

    CAS  Google Scholar 

  24. 24.

    Nishio J, Iwasaki H, Hayashi H, Nabeshima K, Naito M (2014) Soft tissue perineurioma of the foot with 10q24 rearrangements: unique MRI features with histopathologic correlation. Skelet Radiol 43:1017–1022.

    Article  Google Scholar 

  25. 25.

    Papi L, De Vitis LR, Vitelli F, Ammannati F, Mennonna P, Montali E, Bigozzi U (1995) Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas. Hum Genet 95:347–351.

    CAS  Article  Google Scholar 

  26. 26.

    Parry DM, Eldridge R, Kaiser-Kupfer MI, Bouzas EA, Pikus A, Patronas N (1994) Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 52:450–461.

    CAS  Article  Google Scholar 

  27. 27.

    Pitchford CW, Schwartz HS, Atkinson JB, Cates JM (2006) Soft tissue perineurioma in a patient with neurofibromatosis type 2: a tumor not previously associated with the NF2 syndrome. Am J Surg Pathol 30:1624–1629.

    Article  Google Scholar 

  28. 28.

    Plotkin SR, Bredella MA, Cai W, Kassarjian A, Harris GJ, Esparza S, Merker VL, Munn LL, Muzikansky A, Askenazi M, Nguyen R, Wenzel R, Mautner VF (2012) Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis. PLoS One 7:e35711.

    CAS  Article  Google Scholar 

  29. 29.

    Ragel BT, Jensen RL (2005) Molecular genetics of meningiomas. Neurosurg Focus 19:E9.

    Article  Google Scholar 

  30. 30.

    Schulz A, Baader SL, Niwa-Kawakita M, Jung MJ, Bauer R, Garcia C, Zoch A, Schacke S, Hagel C, Mautner VF, Hanemann CO, Dun XP, Parkinson DB, Weis J, Schroder JM, Gutmann DH, Giovannini M, Morrison H (2013) Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy. Nat Neurosci 16:426–433.

    CAS  Article  Google Scholar 

  31. 31.

    Sciot R, Dal Cin P, Hagemeijer A, De Smet L, Van Damme B, Van den Berghe H (1999) Cutaneous sclerosing perineurioma with cryptic NF2 gene deletion. Am J Surg Pathol 23:849–853.

    CAS  Article  Google Scholar 

  32. 32.

    Sperfeld AD, Hein C, Schroder JM, Ludolph AC, Hanemann CO (2002) Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2. Brain 125:996–1004.

    CAS  Article  Google Scholar 

  33. 33.

    Uerschels AK, Krogias C, Junker A, Sure U, Wrede KH, Gembruch O (2020) Modern treatment of perineuriomas: a case-series and systematic review. BMC Neurol 20:55.

    Article  Google Scholar 

  34. 34.

    White B, Belzberg A, Ahlawat S, Blakeley J, Rodriguez FJ (2020) Intraneural perineurioma in neurofibromatosis type 2 with molecular analysis. Clin Neuropathol.

  35. 35.

    Wilson TJ, Howe BM, Stewart SA, Spinner RJ, Amrami KK (2018) Clinicoradiological features of intraneural perineuriomas obviate the need for tissue diagnosis. J Neurosurg 129:1034–1040.

    Article  Google Scholar 

  36. 36.

    Zirn B, Arning L, Bartels I, Shoukier M, Hoffjan S, Neubauer B, Hahn A (2012) Ring chromosome 22 and neurofibromatosis type II: proof of two-hit model for the loss of the NF2 gene in the development of meningioma. Clin Genet 81:82–87.

    CAS  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Robert J. Spinner.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (name of institute/committee) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Retrospective study: For this type of study, formal consent is not required.

Informed consent

Informed consent was obtained from all individual participants included in the study. Retrospective study: For this type of study, formal consent is not required.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Peripheral Nerves

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Pendleton, C., Spinner, R.J., Dyck, P.J.B. et al. Association of intraneural perineurioma with neurofibromatosis type 2. Acta Neurochir (2020).

Download citation


  • Perineurioma
  • Intraneural perineuroma
  • Neurofibromatosis type 2
  • NF2 gene
  • Cytogenetics